Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 386, Issue 1, 2013, Pages 29-39

  Sakurada, Takumi ^a   Ishizawa, Keisuke ^a   Imanishi, Masaki ^a   Izawa Ishizawa, Yuki ^a   Fujii, Shoko ^a   Tominaga, Erika ^a   Tsuneishi, Teppei ^a   Horinouchi, Yuya ^a   Kihira, Yoshitaka ^a   Ikeda, Yasumasa ^a   Tomita, Shuhei ^a   Aihara, Ken Ichi ^a   Minakuchi, Kazuo ^a   Tsuchiya, Koichiro ^a   Tamaki, Toshiaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Angiotensin II; Free radical scavengers; Oxidative stress; Vascular remodeling; Vascular smooth muscle cells

Indexed keywords

8 HYDROXY 20 DEOXYGUANOSINE; ANGIOTENSIN II; CALCIUM; CD68 ANTIGEN; COLLAGEN TYPE 1; EPIDERMAL GROWTH FACTOR RECEPTOR; F4 PROTEIN; GUANOSINE DERIVATIVE; HYDROETHIDINE; LUCIGENIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NIFEDIPINE DERIVATIVE; NITROSONIFEDIPINE; PROTEIN; PROTEIN KINASE B; PROTEIN KINASE C DELTA; PROTEIN P22; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA DISEASE; AORTA FIBROSIS; AORTA REMODELING; ARTERIAL WALL THICKENING; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CHEMOLUMINESCENCE; ELECTRON SPIN RESONANCE; ENZYME PHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; TISSUE LEVEL; URINE LEVEL; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; CALCIUM; CELL MOVEMENT; CELL PROLIFERATION; FIBROSIS; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; NIFEDIPINE; NITROSO COMPOUNDS; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES;

EID: 84872316103     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-012-0810-7     Document Type: Article

References (40)

1. Bauer V, Rekalov VV, Juránek I, Gergel D, Bohov P (1995) Effect of illuminated nifedipine, a potent antioxidant, on intestinal and vascular smooth muscles. Br J Pharmacol 115:871-874
2. Beswick RA, Dorrance AM, Leite R, Webb RC (2001) NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38:1107-1111
3. Cowan DB, Langille BL (1996) Cellular and molecular biology of vascular remodeling. Curr Opin Lipidol 7:94-100
4. Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM (1991) Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 68:450-456
5. Dixon BS, Sharma RV, Dickerson T, Fortune J (1994) Bradykinin and angiotensin II: activation of protein kinase C in arterial smooth muscle. Am J Physiol 266:C1406-1420
6. Ebrahimian T, Li MW, Lemarié CA, Simeone SM, Pagano PJ, Gaestel M, Paradis P, Wassmann S, Schiffrin EL (2011) Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stress. Hypertension 57:245-254
7. Folcik VA, Cathcart MK (1994) Predominance of esterified hydroperoxy-linoleic acid in human monocyte-oxidized LDL. J Lipid Res 35:1570-1582
8. Fujii H, Berliner LJ (1999) In vivo EPR evidence for free radical adducts of nifedipine. Magn Reson Med 42:691-694
9. Fukuhara Y, Tsuchiya K, Horinouchi Y, Tajima S, Kihira Y, Hamano S, Kawazoe K, Ikeda Y, Ishizawa K, Tomita S, Tamaki T (2011) Protective effect of photodegradation product of nifedipine against tumor necrosis factor alpha-induced oxidative stress in human glomerular endothelial cells. J Med Invest 58:118-126
10. Furutani H, Zhang XF, Iwamuro Y, Lee K, Okamoto Y, Takikawa O, Fukao M, Masaki T, Miwa S (2002) Ca2+ entry channels involved in contractions of rat aorta induced by endothelin-1, noradrenaline, and vasopressin. J Cardiovasc Pharmacol 40:265-276
11. Graf K, Xi XP, Yang D, Fleck E, Hsueh WA, Law RE (1997) Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension 29:334-339
12. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148
13. Harrison DG (1997) Endothelial function and oxidant stress. Clin Cardiol 20: II-11-17
14. Horinouchi Y, Tsuchiya K, Taoka C, Tajima S, Kihira Y, Matsuda Y, Shishido K, Yoshida M, Hamano S, Kawazoe K, Ikeda Y, Ishizawa K, Tomita S, Tamaki T (2011) Antioxidant effects of photodegradation product of nifedipine. Chem Pharm Bull (Tokyo) 59:208-214
15. Ikeda Y, Aihara K, Yoshida S, Sato T, Yagi S, Iwase T, Sumitomo Y, Ise T, Ishikawa K, Azuma H, Akaike M, Kato S, Matsumoto T (2009) Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling. Endocrinology 150:2857-2864
16. Inaba S, Iwai M, Furuno M, Kanno H, Senba I, Okayama H, Mogi M, Higaki J, Horiuchi M (2011) Temporary treatment with AT1 receptor blocker, valsartan, from early stage of hypertension prevented vascular remodeling. Am J Hypertens 24:550-556
17. Ishizawa K, Izawa Y, Ito H, Miki C, Miyata K, Fujita Y, Kanematsu Y, Tsuchiya K, Tamaki T, Nishiyama A, Yoshizumi M (2005) Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation. Hypertension 46:1046-1052
18. Ishizawa K, Izawa-Ishizawa Y, Dorjsuren N, Miki E, Kihira Y, Ikeda Y, Hamano S, Kawazoe K, Minakuchi K, Tomita S, Tsuchiya K, Tamaki T (2010) Angiotensin II receptor blocker attenuates PDGF-induced mesangial cell migration in a receptor-independent manner. Nephrol Dial Transplant 25:364-372
19. Ishizawa K, Yamaguchi K, Horinouchi Y, Fukuhara Y, Tajima S, Hamano S, Tomita S, Tsuchiya K, Tamaki T (2009) Drug discovery for overcoming chronic kidney disease (CKD): development of drugs on endothelial cell protection for overcoming CKD. J Pharmacol Sci 109:14-19
20. Ishizawa K, Yoshizumi M, Tsuchiya K, Houchi H, Minakuchi K, Izawa Y, Kanematsu Y, Kagami S, Hirose M, Tamaki T (2004) Dual effects of endothelin-1 (1-31): induction of mesangial cell migration and facilitation of monocyte recruitment through monocyte chemoattractant protein-1 production by mesangial cells. Hypertens Res 27:433-440
21. Izawa Y, Yoshizumi M, Fujita Y, Ali N, Kanematsu Y, Ishizawa K, Tsuchiya K, Obata T, Ebina Y, Tomita S, Tamaki T (2005) ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells. Exp Cell Res 308:291-299
22. Kurobe H, Urata M, Ueno M, Ueki M, Ono S, Izawa-Ishizawa Y, Fukuhara Y, Lei Y, Ripen AM, Kanbara T, Aihara K, Ishizawa K, Akaike M, Gonzalez FJ, Tamaki T, Takahama Y, Yoshizumi M, Kitagawa T, Tomita S (2010) Role of hypoxia-inducible factor 1alpha in T cells as a negative regulator in development of vascular remodeling. Arterioscler Thromb Vasc Biol 30:210-217
23. Letavernier E, Perez J, Bellocq A, Mesnard L, de Castro KA, Haymann JP, Baud L (2008) Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension. Circ Res 102:720-728
24. Mehta PK, Griendling KK (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292:C82-97
25. Misík V, Stasko A, Gergeĺ D, Ondrias K (1991) Spin-trapping and antioxidant properties of illuminated and nonilluminated nifedipine and nimodipine in heart homogenate and model system. Mol Pharmacol 40:435-439
26. Mollnau H, Wendt M, Szöcs K, Lassègue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Förstermann U, Meinertz T, Griendling K, Münzel T (2002) Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90:E58-65
27. Ohkubo T, Noro H, Sugawara K (1992) High-performance liquid chromatographic determination of nifedipine and a trace photodegradation product in hospital prescriptions. J Pharm Biomed Anal 10:67-70
28. Paravicini TM, Touyz RM (2006) Redox signaling in hypertension. Cardiovasc Res 71:247-258
29. Paravicini TM, Touyz RM (2008) NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31(Suppl 2):S170-180
30. Park YM, Park MY, Suh YL, Park JB (2004) NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats. Biochem Biophys Res Commun 313:812-817
31. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97:1916-1923
32. Saward L, Zahradka P (1997) Angiotensin II activates phosphatidylinositol 3-kinase in vascular smooth muscle cells. Circ Res 81:249-257
33. Schwartz SM, deBlois D, O'Brien ER (1995) The intima. Soil for atherosclerosis and restenosis. Circ Res 77:445-465
34. Stasko A, Brezová V, Biskupic S, Ondrias K, Misík V (1994) Reactive radical intermediates formed from illuminated nifedipine. Free Radic Biol Med 17:545-556
35. Tieu BC, Ju X, Lee C, Sun H, Lejeune W, Recinos A, Brasier AR, Tilton RG (2011) Aortic adventitial fibroblasts participate in angiotensin-induced vascular wall inflammation and remodeling. J Vasc Res 48:261-272
36. Virdis A, Neves MF, Amiri F, Touyz RM, Schiffrin EL (2004) Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 22:535-542
37. Wei Y, Whaley-Connell AT, Chen K, Habibi J, Uptergrove GM, Clark SE, Stump CS, Ferrario CM, Sowers JR (2007) NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat. Hypertension 50:384-391
38. Yang X, Zhu MJ, Sreejayan N, Ren J, Du M (2005) Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway. Mol Cells 20:263-270
39. Yoshizumi M, Tsuchiya K, Suzaki Y, Kirima K, Kyaw M, Moon JH, Terao J, Tamaki T (2002) Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochem Biophys Res Commun 293:1458-1465
40. Yáñez C, López-Alarcón C, Camargo C, Valenzuela V, Squella JA, Núñez-Vergara LJ (2004) Structural effects on the reactivity 1,4-dihydropyridines with alkylperoxyl radicals and ABTS radical cation. Bioorg Med Chem 12:2459-2468